Department of Family Medicine, Federal Medical Centre, Keffi, Nasarawa State, Nigeria. Email:
Consultant Family physician, Chief Tony Anenih Geriatric Centre, University College Hospital, Ibadan, Nigeria.
West Afr J Med. 2023 Dec 30;40(12):1347-1354.
Globally, more than 350 million people live with viral hepatitis, out of which over 20 million are in Nigeria. The prevalence of anxiety, depression and stress among patients with viral hepatitis in the primary care setting is not well established.
The objectives of this study were to determine the prevalence and factors associated with depression, anxiety and stress among hepatitis patients in a primary care clinic in North Central Nigeria using the Patient Health Questionnaire (PHQ2), Generalized Anxiety Disorder (GAD 2) and Kessler 6 scales respectively.
This cross-sectional study was carried out among Hepatitis B and C patients attending the Hepatitis Clinic of the Family Medicine Department, Federal Medical Centre Keffi. A total of 123 participants were recruited using a simple random sampling technique. Their sociodemographic and clinical data were collected after which they were screened for depression, anxiety and stress. Data collected was analysed using IBM SPSS.
The mean age of study participants was 38.9±11.6 years. Most of them had hepatitis B infection (89.7%) and were on antiviral medications or liver supplements (45.2%). The prevalence of anxiety, depression and stress among them were found to be 18.9%, 25% and 77.6% respectively. Illness duration and medication use were found to be significantly associated with both depression and stress among them.
The prevalence of anxiety, depression and stress is high among adult primary care patients with viral hepatitis in FMC Keffi.
全球有超过 3.5 亿人患有病毒性肝炎,其中超过 2000 万人在尼日利亚。初级保健环境中,乙型和丙型肝炎患者的焦虑、抑郁和压力的患病率尚不清楚。
本研究的目的是使用患者健康问卷(PHQ2)、广泛性焦虑障碍(GAD2)和 Kessler 6 量表分别确定尼日利亚中北部初级保健诊所中乙型和丙型肝炎患者的抑郁、焦虑和压力的患病率和相关因素。
这是一项横断面研究,在联邦医疗中心凯菲的家庭医学系肝炎诊所对乙型和丙型肝炎患者进行了研究。采用简单随机抽样技术共招募了 123 名参与者。收集他们的社会人口统计学和临床数据,然后对他们进行抑郁、焦虑和压力筛查。使用 IBM SPSS 分析收集的数据。
研究参与者的平均年龄为 38.9±11.6 岁。他们大多患有乙型肝炎感染(89.7%),并正在服用抗病毒药物或肝脏补充剂(45.2%)。他们的焦虑、抑郁和压力的患病率分别为 18.9%、25%和 77.6%。疾病持续时间和药物使用与他们的抑郁和压力都有显著的相关性。
在 FMC Keffi,成年初级保健患者中乙型和丙型肝炎患者的焦虑、抑郁和压力患病率较高。